Optimizing beta-blocker use after myocardial infarction

American Family Physician

Volumn 62, Issue 8, 2000, Pages

  Howard, Patricia A ^a   Ellerbeck, Edward F ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; LABETALOL; METOPROLOL; METOPROLOL TARTRATE; PINDOLOL; PROPRANOLOL; TIMOLOL; TIMOLOL MALEATE;

AGING; CARDIOSELECTIVITY; CARDIOVASCULAR RISK; COMORBIDITY; DIABETES MELLITUS; DOSE RESPONSE; DRUG TOLERABILITY; FATIGUE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HUMAN; MORTALITY; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR;

ADRENERGIC BETA-ANTAGONISTS; CHRONIC DISEASE; DIABETES COMPLICATIONS; DRUG UTILIZATION; HEART FAILURE, CONGESTIVE; HUMANS; HYPERLIPIDEMIAS; LUNG DISEASES; MYOCARDIAL INFARCTION; PATIENT EDUCATION; PHYSICIAN'S PRACTICE PATTERNS; TEACHING MATERIALS; UNITED STATES;

EID: 0034667968     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Quality of care for Medicare patients with acute myocardial infarction: A four-state pilot of the Cooperative Cardiovascular Project
2. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project
3. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction
4. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
5. Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction
6. Beta blockade during and after myocardial infarction: An overview of the randomized trials
7. Subgroup findings from randomized trials in postinfarction patients. The Beta-Blocker Pooling Project Research Group
8. Treatment and outcomes of acute myocardial infarction among patients of cardiologists and generalist physicians
9. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction
10. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results
11. Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina
12. Quality of life on antihypertensive drug therapy: Scientific end-point or marketing exercise?
13. Quality of life in cardiovascular diseases. Emphasis on beta-blocker treatment
14. Management of acute myocardial infarction in the very elderly
15. Diabetic patients and beta-blockers after acute myocardial infarction
16. Effects of metoprolol on mortality and late infarction in diabetics with suspected acute myocardial infarction. Retrospective data from two large studies
17. Timolol treatment after myocardial infarction in diabetic patients
18. Beta-blockers and glucose control
19. Effects of propranolol in non-Q-wave acute myocardial infarction in the beta blocker heart attack trial
20. The Norwegian Multicenter Study of Timolol after Myocardial Infarction
21. Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction
22. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure
23. Effect of beta-blockade on mortality in patients with heart failure: A meta-analysis of randomized clinical trials
24. Effects of beta-blocker therapy on mortality in patients with heart failure. A systemic overview of randomized controlled trials
25. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group
26. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
27. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
28. Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure
29. Beta-blockers and sudden cardiac death
30. The effect of metoprolol and practolol on lung function and blood pressure in hypertensive asthmatics
31. Beta-adrenoceptor blockers and terbutaline in patients with chronic obstructive lung disease. Effects and interaction after oral administration
32. Esmolol and ventilatory function in cardiac patients with COPD
33. Effect of beta-blocking drugs, on peripheral blood flow in intermittent claudication
34. Beta-adrenergic blockade and peripheral vascular disease
35. Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease